Henry Schein (HSIC) 10-Q 2 Aug 22 2022 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 25, 2022	Jul. 25, 2022
Cover [Abstract]
Entity Central Index Key	0001000228
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 25, 2022
Document Transition Report	false
Entity Registrant Name	HENRY SCHEIN, INC.
Entity File Number	0-27078
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3136595
Entity Address, Address Line One	135 Duryea Road
Entity Address, City or Town	Melville
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11747
City Area Code	631
Local Phone Number	843-5500
Title of 12(b) Security	Common Stock, par value $.01 per share
Trading Symbol	HSIC
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		136,114,744

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021
Current assets:
Cash and cash equivalents	$ 108	$ 118
Accounts receivable, net of reserves of $63 and $67	1,409	1,452
Inventories, net	1,823	1,861
Prepaid expenses and other	449	413
Total current assets	3,789	3,844
Property and equipment, net	356	366
Operating lease right-of-use assets	327	325
Goodwill	2,833	2,854
Other intangibles, net	603	668
Investments and other	416	424
Total assets	8,324	8,481
Current liabilities:
Accounts payable	901	1,054
Bank credit lines	85	51
Current maturities of long-term debt	4	11
Operating lease liabilities	74	76
Accrued expenses:
Payroll and related	328	385
Taxes	124	137
Other	560	593
Total current liabilities	2,076	2,307
Long-term debt	769	811
Deferred income taxes	33	42
Operating lease liabilities	276	268
Other liabilities	357	377
Total liabilities	3,511	3,805
Redeemable noncontrolling interests	586	613
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.01 par value, 1,000,000 shares authorized, none outstanding	0	0
Common stock, $0.01 par value, 480,000,000 shares authorized, 136,439,560 outstanding on June 25, 2022 and 137,145,558 outstanding on December 25, 2021	1	1
Additional paid-in capital	0	0
Retained earnings	3,834	3,595
Accumulated other comprehensive loss	(241)	(171)
Total Henry Schein, Inc. stockholders' equity	3,594	3,425
Noncontrolling interests	633	638
Total stockholders' equity	4,227	4,063
Total liabilities, redeemable noncontrolling interests and stockholders' equity	$ 8,324	$ 8,481

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021
Current assets:
Accounts receivable, reserves (in dollars)	$ 63	$ 67
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	480,000,000	480,000,000
Common stock, shares outstanding (in shares)	136,439,560	137,145,558

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
CONDENSED CONSOLIDATED STATEMENTS OF INCOME [Abstract]
Net sales	$ 3,030	$ 2,967	$ 6,209	$ 5,892
Cost of sales	2,085	2,076	4,291	4,110
Gross profit	945	891	1,918	1,782
Operating expenses:
Selling, general and administrative	680	635	1,362	1,249
Depreciation and amortization	45	45	92	89
Restructuring costs	0	1	0	4
Operating income	220	210	464	440
Other income (expense):
Interest income	3	1	5	3
Interest expense	(9)	(7)	(16)	(13)
Other, net	0	1	0	1
Income before taxes, equity in earnings of affiliates and noncontrolling interests	214	205	453	431
Income taxes	(52)	(47)	(109)	(104)
Equity in earnings of affiliates	5	6	9	12
Net income	167	164	353	339
Less: Net income attributable to noncontrolling interests	(7)	(8)	(12)	(17)
Net income attributable to Henry Schein, Inc.	$ 160	$ 156	$ 341	$ 322
Earnings per share attributable to Henry Schein, Inc.:
Basic (in dollars per share)	$ 1.17	$ 1.11	$ 2.49	$ 2.28
Diluted (in dollars per share)	$ 1.16	$ 1.10	$ 2.46	$ 2.26
Weighted-average common shares outstanding:
Basic (in shares)	137,350,488	140,358,428	137,323,076	141,316,258
Diluted (in shares)	138,869,064	141,656,883	139,055,205	142,537,906

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]
Net income	$ 167	$ 164	$ 353	$ 339
Other comprehensive income (loss), net of tax:
Foreign currency translation gain (loss)	(90)	38	(87)	0
Unrealized gain (loss) from foreign currency hedging activities	8	(2)	9	1
Pension adjustment gain	0	0	0	1
Other comprehensive income (loss), net of tax	(82)	36	(78)	2
Comprehensive income	85	200	275	341
Comprehensive income attributable to noncontrolling interests:
Net income	(7)	(8)	(12)	(17)
Foreign currency translation (gain) loss	9	(7)	8	(1)
Comprehensive (income) loss attributable to noncontrolling interests	2	(15)	(4)	(18)
Comprehensive income attributable to Henry Schein, Inc.	$ 87	$ 185	$ 271	$ 323

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interests [Member]
Beginning Balance at Dec. 26, 2020	$ 3,984	$ 1	$ 0	$ 3,455	$ (108)	$ 636
Beginning Balance, shares (in shares) at Dec. 26, 2020		142,462,571
Net income (excluding amounts attributable to Redeemable noncontrolling interests)	325	$ 0	0	322	0	3
Foreign currency translation gain (loss) (excluding gain (loss) amounts attributable to Redeemable noncontrolling interests)	(1)	0	0	0	(1)	0
Unrealized gain from foreign currency hedging activities, net of tax	1	0	0	0	1	0
Pension adjustment gain, net of tax	1	0	0	0	1	0
Change in fair value of redeemable securities	(133)	0	(133)	0	0	0
Initial noncontrolling interest and adjustments related to business acquisitions	7	0	0	0	0	7
Repurchase and retirement of common stock - Value	(201)	$ 0	(27)	(174)	0	0
Repurchase and retirement of common stock - Shares		(2,867,557)
Stock-based compensation expense - Value	30	$ 0	30	0	0	0
Stock-based compensation expense - Shares		299,561
Shares withheld for payroll taxes - Value	(7)	$ 0	(7)	0	0	0
Shares withheld for payroll taxes - Shares		(113,734)
Transfer of charges in excess of capital	0	$ 0	137	(137)	0	0
Ending Balance at Jun. 26, 2021	4,006	$ 1	0	3,466	(107)	646
Ending Balance, shares (in shares) at Jun. 26, 2021		139,780,841
Beginning Balance at Mar. 27, 2021	3,997	$ 1	0	3,493	(136)	639
Beginning Balance, shares (in shares) at Mar. 27, 2021		141,310,113
Net income (excluding amounts attributable to Redeemable noncontrolling interests)	157	$ 0	0	156	0	1
Foreign currency translation gain (loss) (excluding gain (loss) amounts attributable to Redeemable noncontrolling interests)	31	0	0	0	31	0
Unrealized gain from foreign currency hedging activities, net of tax	(2)	0	0	0	(2)	0
Pension adjustment gain, net of tax	0
Change in fair value of redeemable securities	(87)	0	(87)	0	0	0
Initial noncontrolling interest and adjustments related to business acquisitions	6	0	0	0	0	6
Repurchase and retirement of common stock - Value	(112)	$ 0	(15)	(97)	0	0
Repurchase and retirement of common stock - Shares		(1,542,315)
Stock-based compensation expense - Value	17	$ 0	17	0	0	0
Stock issued upon exercise of stock options - Value	0	$ 0	0	0	0	0
Stock issued upon exercise of stock options - Shares		17,916
Shares withheld for payroll taxes - Value	0	$ 0	0	0	0	0
Shares withheld for payroll taxes - Shares		(4,873)
Settlement of stock-based compensation awards - Value	(1)	$ 0	(1)	0	0	0
Transfer of charges in excess of capital	0	0	86	(86)	0	0
Ending Balance at Jun. 26, 2021	4,006	$ 1	0	3,466	(107)	646
Ending Balance, shares (in shares) at Jun. 26, 2021		139,780,841
Beginning Balance at Dec. 25, 2021	$ 4,063	$ 1	0	3,595	(171)	638
Beginning Balance, shares (in shares) at Dec. 25, 2021	137,145,558	137,145,558
Net income (excluding amounts attributable to Redeemable noncontrolling interests)	$ 344	$ 0	0	341	0	3
Foreign currency translation gain (loss) (excluding gain (loss) amounts attributable to Redeemable noncontrolling interests)	(80)	0	0	0	(79)	(1)
Unrealized gain from foreign currency hedging activities, net of tax	9	0	0	0	9	0
Pension adjustment gain, net of tax	0
Purchase of noncontrolling interests	(7)	0	0	0	0	(7)
Change in fair value of redeemable securities	7	0	7	0	0	0
Repurchase and retirement of common stock - Value	(110)	$ 0	(16)	(94)	0	0
Repurchase and retirement of common stock - Shares		(1,345,397)
Stock-based compensation expense - Value	27	$ 0	27	0	0	0
Stock-based compensation expense - Shares		954,899
Stock issued upon exercise of stock options - Value	$ 2	$ 0	2	0	0	0
Stock issued upon exercise of stock options - Shares	29,892	29,827
Shares withheld for payroll taxes - Value	$ (29)	$ 0	(29)	0	0	0
Shares withheld for payroll taxes - Shares		(342,347)
Settlement of stock-based compensation awards - Value	1	$ 0	1	0	0	0
Settlement of stock-based compensation awards - Shares		(2,980)
Transfer of charges in excess of capital	0	$ 0	8	(8)	0	0
Ending Balance at Jun. 25, 2022	$ 4,227	$ 1	0	3,834	(241)	633
Ending Balance, shares (in shares) at Jun. 25, 2022	136,439,560	136,439,560
Beginning Balance at Mar. 26, 2022	$ 4,224	$ 1	0	3,759	(168)	632
Beginning Balance, shares (in shares) at Mar. 26, 2022		137,708,809
Net income (excluding amounts attributable to Redeemable noncontrolling interests)	162	$ 0	0	160	0	2
Foreign currency translation gain (loss) (excluding gain (loss) amounts attributable to Redeemable noncontrolling interests)	(82)	0	0	0	(81)	(1)
Unrealized gain from foreign currency hedging activities, net of tax	8	0	0	0	8	0
Pension adjustment gain, net of tax	0
Change in fair value of redeemable securities	10	0	10	0	0	0
Repurchase and retirement of common stock - Value	(110)	$ 0	(16)	(94)	0	0
Repurchase and retirement of common stock - Shares		(1,345,397)
Stock-based compensation expense - Value	15	$ 0	15	0	0	0
Stock-based compensation expense - Shares		78,738
Stock issued upon exercise of stock options - Value	0	$ 0	0	0	0	0
Stock issued upon exercise of stock options - Shares		3,594
Shares withheld for payroll taxes - Value	(1)	$ 0	(1)	0	0	0
Shares withheld for payroll taxes - Shares		(6,016)
Settlement of stock-based compensation awards - Value	1	$ 0	1	0	0	0
Settlement of stock-based compensation awards - Shares		(168)
Transfer of charges in excess of capital	0	$ 0	(9)	9	0	0
Ending Balance at Jun. 25, 2022	$ 4,227	$ 1	$ 0	$ 3,834	$ (241)	$ 633
Ending Balance, shares (in shares) at Jun. 25, 2022	136,439,560	136,439,560

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021	Dec. 25, 2021
Net income attributable to Redeemable noncontrolling interests	$ 5	$ 7	$ 9	$ 14	$ 23
Foreign currency translation gain (loss) attributable to Redeemable noncontrolling interests	(8)	7	(7)	1	$ (6)
Unrealized gain (loss) from foreign currency hedging activities, tax	2	0	3	1
Pension adjustment gain, tax	$ 0	$ 0	$ 0	$ 0

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021
Cash flows from operating activities:
Net income	$ 353	$ 339
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	108	99
Stock-based compensation expense	27	30
Benefit from losses on trade and other accounts receivable	0	(4)
Provision for (benefit from) deferred income taxes	(15)	6
Equity in earnings of affiliates	(9)	(12)
Distributions from equity affiliates	10	11
Changes in unrecognized tax benefits	(1)	(6)
Other	(13)	3
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	21	102
Inventories	4	(124)
Other current assets	(37)	(86)
Accounts payable and accrued expenses	(198)	(136)
Net cash provided by operating activities	250	222
Cash flows from investing activities:
Purchases of fixed assets	(43)	(32)
Payments related to equity investments and business acquisitions, net of cash acquired	(7)	(296)
Proceeds from (payments for) loan to affiliate	6	(2)
Other	(15)	(11)
Net cash used in investing activities	(59)	(341)
Cash flows from financing activities:
Net change in bank borrowings	30	(5)
Proceeds from issuance of long-term debt	0	200
Principal payments for long-term debt	(57)	(120)
Proceeds from issuance of stock upon exercise of stock options	2	0
Payments for repurchases and retirement of common stock	(110)	(201)
Payments for taxes related to shares withheld for employee taxes	(29)	(8)
Distributions to noncontrolling shareholders	(12)	(4)
Acquisitions of noncontrolling interests in subsidiaries	(19)	(1)
Net cash used in financing activities	(195)	(139)
Effect of exchange rate changes on cash and cash equivalents	(6)	4
Net change in cash and cash equivalents	(10)	(254)
Cash and cash equivalents, beginning of period	118	421
Cash and cash equivalents, end of period	$ 108	$ 167

Basis of Presentation

Basis of Presentation	6 Months Ended
	Jun. 25, 2022
Basis of Presentation [Abstract]
Basis of Presentation	Note 1 – Basis of Presentation Our condensed consolidated financial statements include the accounts of Henry controlled subsidiaries (“we”, “us” or “our”). consolidation. financial decisions are accounted for under the equity method. to conform to the current period presentation. Our accompanying unaudited condensed consolidated financial statements accounting principles generally accepted in the United States with the instructions to Form 10-Q and Article 10 of Regulation S-X. information and footnote disclosures required by U.S. GAAP for complete The unaudited interim condensed consolidated financial statements should be consolidated financial statements and notes to the consolidated financial on Form 10-K for the year ended December 25, 2021 and with the information available filings with the Securities and Exchange Commission. reflect all adjustments considered necessary for a fair presentation of financial position for the interim periods presented. The preparation of financial statements in conformity with accounting principles States requires us to make estimates and assumptions that affect the reported amounts of disclosure of contingent assets and liabilities at the date of the financial revenues and expenses during the reporting period. operations for the six months ended June 25, 2022 are not necessarily indicative any other interim period or for the year ending December 31, 2022. We consolidate the results of operations and financial position of a trade accounts receivable securitization which we consider a Variable Interest Entity (“VIE”) because we are the primary beneficiary, and we have the power to direct activities that most significantly affect the economic performance and have majority of the losses or benefits. collateral to the related debt. June 25, 2022 and December 25, 2021, certain trade accounts receivable of this VIE were $ 76 138 recourse to us were $ 60 105 Our condensed consolidated financial statements reflect estimates and other things, our goodwill, long-lived asset and definite-lived intangible investment valuation; assessment of the annual effective tax rate; valuation of tax contingencies; the allowance for doubtful accounts; hedging activity; compensation cost for certain share-based performance awards and cash bonus assumptions. regarding estimates and impairments could change in the future. pandemic may again have a material adverse effect on our business, results of operations result in a material adverse effect on our financial condition and liquidity. impact cannot be reasonably estimated at this time

Critical Accounting Policies, A

Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards	6 Months Ended
	Jun. 25, 2022
Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards [Abstract]
Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards	Note 2 – Critical Accounting Policies, Accounting Pronouncements Adopted Standards Critical Accounting Policies There have been no material changes in our critical accounting policies as compared to the critical accounting policies described in Item 7 of our Annual ended December 25, 2021. Accounting Pronouncements Adopted On December 26, 2021 Contract Assets and Contract Liabilities from Contracts with Customers” ASU was permitted. liabilities acquired in a business combination in accordance with Topic 606. should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. To achieve this, an acquirer may assess how the acquiree applied Topic 606 to determine what to record for the acquired revenue contracts. contract assets and contract liabilities consistent with how financial statements. adoption statements. Recently Issued Accounting Standards In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional expedients and exceptions for applying U.S. GAAP to contracts, transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or reference rate expected to be discontinued because of reference rate reform. March 12, 2020 and can be applied prospectively through December 31, ASU 2021-01, Reference Rate Reform (Topic 848): Scope (“ASU 2021-01”). optional expedients and exceptions to certain guidance in U.S. GAAP to ease to the expected market transition from LIBOR and other interbank offered rates as the Secured Overnight Financing Rate. applied through December 31, 2022. impact on our consolidated financial statements. In March 2022, the FASB issued ASU No. 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Portfolio Layer Method,” which will expand companies' abilities portfolios of financial assets (or beneficial interests) in a fair value hedge. portfolio layer method (previously referred to as the last-of-layer closed portfolio of assets using spot starting, forward starting and amortizing-notional prepayable and non-prepayable financial assets to be included in the closed layer hedge. portfolio layer method hedges, but rather be maintained on the closed portfolio 01 is effective for fiscal years beginning after December 15, 2022, including interim periods years. expect that the requirements of this guidance will have a material impact In March 2022, the FASB issued ASU No. 2022-02, “Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructuring and Vintage Disclosures”. troubled debt restructurings by creditors that have adopted the Current Expected the disclosure requirements for loan refinancings and restructurings difficulty. for financing receivables and net investment in leases by year of origination – 02 is effective for fiscal years beginning after December 15, 2022, including years. Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”. expect that the requirements of this guidance will have a material impact

Revenue from Contracts with Cus

Revenue from Contracts with Customers	6 Months Ended
	Jun. 25, 2022
Revenue from Contracts with Customers [Abstract]
Revenue from Contracts with Customers	Note 3 – Revenue from Contracts with Customers Revenue is recognized in accordance with policies disclosed in Item 8 of our the year ended December 25, 2021. Disaggregation of Net Sales The following table disaggregates our Net sales by reportable segment and geographic Three Months Ended Six Months Ended June 25, 2022 June 25, 2022 North America International Global North America International Global Net Sales: Health care distribution Dental $ 1,124 $ 729 $ 1,853 $ 2,229 $ 1,452 $ 3,681 Medical 977 19 996 2,127 41 2,168 Total health care distribution 2,101 748 2,849 4,356 1,493 5,849 Technology 158 23 181 314 46 360 Total revenues $ 2,259 $ 771 $ 3,030 $ 4,670 $ 1,539 $ 6,209 Three Months Ended Six Months Ended June 26, 2021 June 26, 2021 North America International Global North America International Global Net Sales: Health care distribution Dental $ 1,129 $ 783 $ 1,912 $ 2,174 $ 1,527 $ 3,701 Medical 875 27 902 1,838 55 1,893 Total health care distribution 2,004 810 2,814 4,012 1,582 5,594 Technology 131 22 153 255 43 298 Total revenues $ 2,135 $ 832 $ 2,967 $ 4,267 $ 1,625 $ 5,892 At December 25, 2021, the current portion of contract liabilities of $ 89 Other, and $ 10 months ended June 25, 2022, we recognized in net sales $ 56 December 25, 2021. 87 and $ 9

Segment Data

Segment Data	6 Months Ended
	Jun. 25, 2022
Segment Data [Abstract]
Segment Data	Note 4 Segment Data We conduct our business through two value-added services. These segments offer different products and services to the same customer dental businesses serve office-based dental practitioners, dental laboratories, schools and global medical businesses serve office-based medical practitioners, ambulatory settings and other institutions. Our global dental and medical groups serve 32 The health care distribution reportable segment aggregates our global segment distributes consumable products, dental specialty products, equipment, equipment repair services, branded and generic pharmaceuticals, tests, infection-control products, personal protective equipment (“PPE”) Our global technology and value-added services reportable segment provides added services to health care practitioners. Our technology offerings include practice for dental and medical practitioners. Our value-added practice solutions revenue cycle management and financial services on a non-recourse basis, and hardware services, as well as continuing education services for practitioners. The following tables present information about our reportable and operating segments: Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Net Sales: Health care distribution Dental $ 1,853 $ 1,912 $ 3,681 $ 3,701 Medical 996 902 2,168 1,893 Total health care distribution 2,849 2,814 5,849 5,594 Technology 181 153 360 298 Total $ 3,030 $ 2,967 $ 6,209 $ 5,892 Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Operating Income: Health care distribution $ 189 $ 182 $ 400 $ 379 Technology 31 28 64 61 Total $ 220 $ 210 $ 464 $ 440

Business Acquisitions

Business Acquisitions	6 Months Ended
	Jun. 25, 2022
Business Acquisitions [Abstract]
Business Acquisitions	Note 5 Business Acquisitions 2022 Acquisitions During the six months ended June 25, 2022, we made several acquisitions services segments. financial statements. 2021 Acquisitions We completed several acquisitions during the six months ended June 26, 2021 which were immaterial to our financial statements. 51 % to 100 %. within our health care distribution segment included provider of home medical supplies, and product kitting and sterile packaging. added services segment, we acquired companies that focus on dental transition services, and business analytics and intelligence software. The following table aggregates the estimated fair value, as of the assets acquired for acquisitions during the six months ended June 26, 2021. assumptions to accurately value those assets acquired and liabilities contingent consideration, where applicable, our estimates are inherently uncertain result, during the measurement period we may record adjustments with the corresponding offset to goodwill within our condensed consolidated balance sheets. Acquisition consideration: Cash $ 303 Deferred consideration 8 Redeemable noncontrolling interests 129 Total consideration $ 440 Identifiable assets acquired and liabilities assumed: Current assets 107 Intangible assets 184 Other noncurrent assets 34 Current liabilities (44) Deferred income taxes (17) Other noncurrent liabilities (37) Total identifiable 227 Goodwill 213 Total net assets acquired $ 440 The following table summarizes the identifiable intangible assets acquired 2021 and their estimated useful lives as of the date of the acquisition: Estimated Useful Lives (in years) Customer relationships and lists $ 124 5 - 12 Trademark / Tradename 33 5 - 7 Non-compete agreements 6 5 Product development 21 5 - 7 Total $ 184 The major classes of assets and liabilities that we generally allocate purchase identifiable intangible assets (i.e., customer relationships and lists, trademarks development and non-compete agreements), inventory and accounts deferred taxes and other current and long-term assets and liabilities. intangible assets is based on critical estimates, judgments and assumptions conditions, discount rates, discounted cash flows, customer retention rates Some prior owners of acquired subsidiaries are eligible to receive additional certain financial targets are met. price consideration at the time of the acquisition. condensed consolidated statements of income. were no material adjustments recorded in our condensed consolidated statements estimated contingent purchase price liabilities. During the six months ended June 25, 2022 and June 26, 2021 we 3 4 in acquisition costs.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 25, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	Note 6 – Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or transaction between market participants at the measurement date. (1) market participant assumptions developed based on market data obtained inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the in active markets for identical assets or liabilities (Level 1) and the lowest priority The three levels of the fair value hierarchy are described as follows: • measurement date. • either directly or indirectly. quoted prices for identical or similar assets or liabilities in markets prices that are observable for the asset or liability; and inputs that are observable market data by correlation or other means. • The following section describes the fair values of our financial instruments measure their fair values. Investments and notes receivable There are no quoted market prices available for investments in unconsolidated however, we believe the carrying amounts are a reasonable estimate of fair value based on the interest rates applicable markets. Debt The fair value of our debt (including bank credit lines) is classified as as of June 25, 2022 and December 25, 2021 was estimated at $ 858 873 that we considered when estimating the fair value of our debt included credit spreads. Derivative contracts Derivative contracts are valued using quoted market prices and significant derivative instruments to minimize our exposure to fluctuations in foreign instruments primarily include foreign currency forward agreements related forecasted inventory purchase commitments with foreign suppliers, portion of our euro-denominated foreign operations which are designated return swap for the purpose of economically hedging our unfunded non-qualified plan and our deferred compensation plan. The fair values for the majority of our foreign currency derivative contracts rate to a published forward price of the underlying market rates, which transactions and are classified within Level 2 of the fair value hierarchy. Redeemable noncontrolling interests The values for Redeemable noncontrolling interests are classified within based on recent transactions and/or implied multiples of earnings. for additional information. The following table presents our assets and liabilities that are measured and basis classified under the appropriate level of the fair value hierarchy as of June 25, 2022 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 23 $ - $ 23 Derivative contracts undesignated - 2 - 2 Total assets $ - $ 25 $ - $ 25 Liabilities: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 5 - 5 Total return - 5 - 5 Total liabilities $ - $ 11 $ - $ 11 Redeemable noncontrolling interests $ - $ - $ 586 $ 586 December 25, 2021 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 8 $ - $ 8 Derivative contracts undesignated - 1 - 1 Total return - 1 - 1 Total assets $ - $ 10 $ - $ 10 Liabilities: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 2 - 2 Total liabilities $ - $ 3 $ - $ 3 Redeemable noncontrolling interests $ - $ - $ 613 $ 613

Debt

Debt	6 Months Ended
	Jun. 25, 2022
Debt [Abstract]
Debt	Note 7 – Debt Bank Credit Lines Bank credit lines consisted of the following: June 25, December 25, 2022 2021 Revolving credit agreement $ - $ - Other short-term bank credit lines 85 51 Total $ 85 $ 51 Revolving Credit Agreement On August 20, 2021 , we entered into a new $ 1 facility which matures on August 20, 2026 750 to mature in April 2022. the end of each financial reporting quarter. while the remaining LIBOR rates will be discontinued immediately discontinuation of LIBOR as a reference rate in our debt agreements financial position or to materially affect our interest expense. things, that we maintain certain maximum leverage ratios. representations, warranties and affirmative covenants as well as customary negative negotiated exceptions, on liens, indebtedness, significant corporate changes certain restrictive agreements. no revolving credit facility. 9 9 letters of credit, respectively, provided to third parties under the credit facility. Other Short-Term Bank Credit As of June 25, 2022 and December 25, 2021, we had various other short-term $ 85 51 under all of these credit lines had a weighted average interest rate 9.90 % and 10.44 %, respectively. Long-term debt Long-term debt consisted of the following: June 25, December 25, 2022 2021 Private placement facilities $ 699 $ 706 U.S. trade accounts receivable securitization 60 105 Various in varying installments through 2023 at interest rates ranging from 0.00 % to 3.50 % at June 25, 2022 and ranging from 2.62 % to 4.27 % at December 25, 2021 7 4 Finance lease obligations 7 7 Total 773 822 Less current maturities (4) (11) Total long-term debt $ 769 $ 811 Private Placement Facilities Our private placement facilities were amended on October 20, 2021 four three ) insurance companies, have a total facility amount of $ 1.5 1.0 uncommitted basis at fixed rate economic terms to be agreed upon at through October 20, 2026 June 23, 2023 ). the lenders at a fixed rate based on an agreed upon spread over applicable issuance. five 15 years average life no longer than 12 years ). corporate purposes, including working capital and capital expenditures, to fund potential acquisitions. leverage ratios, and contain restrictions relating to subsidiary indebtedness, assets and certain changes in ownership. off the facilities prior to the applicable due dates. The components of our private placement facility borrowings as table: Amount of Borrowing Borrowing Date of Borrowing Outstanding Rate Due Date January 20, 2012 $ 50 3.45 % January 20, 2024 December 24, 2012 50 3.00 December 24, 2024 June 16, 2017 100 3.42 June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 Less: Deferred debt issuance costs (1) Total $ 699 U.S. Trade Accounts Receivable Securitization We have a facility agreement based on the securitization of our U.S. trade accounts receivable that is structured as an asset-backed securitization program with pricing committed for up three years . had a purchase limit of $ 350 April 29, 2022 . amended our U.S. trade accounts receivable securitization facility to 450 with two October 18, 2024 . 25, 2021, the borrowings outstanding under this securitization facility were 60 105 respectively. commercial paper rate of 1.43 % plus 0.75 %, for a combined rate of 2.18 %. on borrowings under this facility was based on the asset-backed commercial 0.19 % plus 0.75 %, for a combined rate of 0.94 %. If our accounts receivable collection pattern changes due to customers our ability to borrow under this facility may be reduced. We are required to pay a commitment fee of 30 35

Income Taxes

Income Taxes	6 Months Ended
	Jun. 25, 2022
Income Taxes [Abstract]
Income Taxes	Note 8 – Income Taxes For the six months ended June 25, 2022 our effective tax rate was 23.9 % compared to 24.3 % for the prior year period. June 25, 2022 primarily relates to state and foreign income taxes and compensation. ended June 26, 2021 primarily relates to state and foreign income taxes, credits associated with legal entity reorganizations. The total amount of unrecognized tax benefits, which are included in “Other consolidated balance sheets, as of June 25, 2022 and December 25, 2021 83 84 respectively of which $ 69 69 is possible that the amount of unrecognized tax benefits will change material impact on our condensed consolidated statements of income. All tax returns audited by the IRS are officially closed through 2016. IRS include years 2017 and forward. that tax year 2019 was selected for examination. During the quarter ended September 26, 2020 we reached an agreement appropriate transfer pricing methodology for the years 2014-2025. future transfer pricing audit adjustments. The total amounts of interest and penalties are classified as a component amount of tax interest expense/(credit) was $ 0 (3) the six months ended June 26, 2021. $ 13 12 No periods presented.

Legal Proceedings

Legal Proceedings	6 Months Ended
	Jun. 25, 2022
Legal Proceedings [Abstract]
Legal Proceedings	Note 9 – Legal Proceedings Henry Schein, Inc. has been named as a defendant in multiple lawsuits ( 150 ); in less than half of those cases one or more of Henry Schein, defendant). advertising campaign to expand the market for such drugs and their own supply chain (including Henry Schein, Inc and its affiliated companies) reaped financial otherwise failing to monitor appropriately and restrict the improper distribution consist of some that have been consolidated within the MultiDistrict Litigation Prescription Opiate Litigation (MDL No. 2804; Case No. 17-md-2804) remain pending in state courts and are proceeding independently and outside following cases are set for trial: the action filed by Mobile County Board which is currently set for a jury trial on January 9, 2023; the action filed Alabama state court, which is currently scheduled for a jury trial on July 24, 2023; Health Sciences Center, Inc. (and 38 which is currently scheduled for a jury trial in October 2024. twenty-six hospitals in West Virginia, one three-hundred thousand dollars. twenty-six 12.4 sales of opioids represented less than two-tenths We intend to defend ourselves vigorously against these actions. From time to time, we may become a party to other legal proceedings, liability claims, employment matters, commercial disputes, governmental in some cases involve our entering into settlement arrangements or consent of the ordinary course of our business. in our opinion none of these other pending matters are currently consolidated financial position, liquidity or results of operations. As of June 25, 2022, we had accrued our best estimate of potential result in liability and for which we were able to reasonably estimate a expenses, was not material to our financial position, results of operations determining estimated losses considers currently available factors, including probable recoveries from third parties.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 25, 2022
Stock-Based Compensation [Abstract]
Stock-Based Compensation	Note 10 – Stock-Based Compensation Stock-based awards are provided to certain employees under the terms of non-employee directors under the terms of our 2015 Non-Employee Director “Plans”). “Compensation Committee”). form of time-based and performance-based restricted stock units (“RSUs”). light of the COVID-19 pandemic, the Compensation Committee determined to set a meaningful three-year cumulative earnings per share target as the goal applicable restricted stock unit awards as it had done in prior years. based awards to employees for fiscal 2021 in the form of time-based RSUs focus on stock value appreciation and retention instead of pre-established directors continued to receive equity-based awards for fiscal 2021 2022, the Compensation Committee reinstated performance-based fiscal 2022 and awarded grants in the form of time-based RSUs, performance-based options. RSUs are stock-based awards granted to recipients with specified vesting provisions. stock is generally delivered on or following satisfaction of vesting conditions. vest (i) solely based on the recipient’s continued service over time, primarily with four -year cliff vesting and/or (ii) based on achieving specified performance measurements and the recipient’s continued service over time, primarily with three -year cliff vesting. are granted with 12 -month cliff vesting. straight-line basis. With respect to time-based RSUs, we estimate the fair value on the date of grant based on our closing the time of grant. received by the recipient is based upon our performance as measured against period, as determined by the Compensation Committee. will be achieved, we estimate the fair value of performance-based RSUs grant. Each of the Plans provide for certain adjustments to the performance the Plans. performance measurement adjustments relate to significant events, including, divestitures, new business ventures, certain capital transactions (including share budgeted average outstanding shares (other than those resulting from capital restructuring costs, if any, certain litigation settlements or payments, if any, changes in accounting principles or in applicable laws or regulations, changes in income tax rates in certain markets, financial impact, either positive or negative, of the differences in projected earnings 19 test kits (solely with respect to performance-based RSUs circumstances affecting us. Over the performance period, the number of shares of common stock that will related compensation expense is adjusted upward or downward based upon performance targets. recognized as an expense will be based on our actual performance metrics Stock options are awards that allow the recipient to purchase shares of our vesting of the stock options. date of grant. one-third service, subject to the terms and conditions of the 2020 Stock Incentive Plan, three years grant date and have a contractual term of ten years upon certain events. We estimate the fair value of stock options using the Black-Scholes valuation model. In addition to equity-based awards granted in fiscal 2021 under the our long-term Compensation Committee granted a Special Pandemic Recognition Award under the 2020 Stock Incentive Plan to recipients of performance-based RSUs under the 2018 long-term performance-based restricted stock units granted under the fiscal 2018 long-term LTIP”) was negatively impacted by the global COVID-19 pandemic. pandemic on our three-year (including those who received such awards), on March 3, 2021, the Compensation Pandemic Recognition Award to recipients of performance-based restricted stock units under the 2018 LTIP who were employed by us on the grant date of the Special Pandemic awards vest 50 % on the first anniversary of the grant date and 50 % on the second anniversary of the grant date, based on the recipient’s continued service and subject to the terms and conditions of the 2020 Stock Incentive and are recorded as compensation expense using a graded vesting 20 % payout based on actual performance of the 2018 LTIP and the one-time Special Pandemic Recognition Award granted in 2021 will generate a cumulative payout of 75 % of each recipient’s original number of performance-based restricted stock units awarded in 2018 if the recipient satisfies the two-year Our accompanying condensed consolidated statements of income reflect of $ 15 12 27 21 June 25, 2022, respectively. compensation expense of $ 17 13 30 23 Total unrecognized compensation cost related to unvested awards as of June 25, 2022 was $ 116 expected to be recognized over a weighted-average period of approximately 2.4 Our accompanying condensed consolidated statements of cash flows present as an adjustment to reconcile net income to net cash provided by operating the accompanying condensed consolidated statements of cash flows, there were no deductions in excess of recognized compensation as a cash inflow from ended June 25, 2022 and June 26, 2021, respectively. The following weighted-average assumptions were used in determining granted using the Black-Scholes valuation model: 2022 Expected dividend yield 0.0 % Expected stock price volatility 27.40 % Risk-free interest rate 3.25 % Expected life of options (years) 6.00 We have not declared cash dividends on our stock in the past and we do not anticipate declaring cash dividends in the foreseeable future. our stock, historical volatility of our stock, and other factors. Treasury yield curve in effect at the time of grant in conjunction with considering the expected life of options. six-year expected life of the options was determined using the simplified as permitted under SAB Topic 14. value ultimately realized by recipients of stock options, and subsequent reasonableness of the original estimates of fair value made by us. The following table summarizes stock option activity under the Plans Stock Options Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Life in Shares Price Years Outstanding at beginning of period 767,717 $ 63.24 Granted 406,443 86.16 Exercised (29,892) 62.71 Forfeited (9,656) 71.72 Outstanding at end of period 1,134,612 $ 71.39 9.1 $ 10 Options exercisable at end of period 219,642 $ 62.92 Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Options Price Life (in years) Value Vested 894,356 $ 73.68 9.2 $ 7 The following tables summarize the activity of our unvested RSUs for the six Time-Based Restricted Stock Units Weighted Average Grant Date Fair Intrinsic Value Shares/Units Value Per Share Per Share Outstanding at beginning of period 1,945,862 $ 58.79 Granted 455,169 86.13 Vested (501,944) 54.76 Forfeited (28,807) 65.88 Outstanding at end of period 1,870,280 $ 66.47 $ 77.29 Performance-Based Restricted Stock Units Weighted Average Grant Date Fair Intrinsic Value Shares/Units Value Per Share Per Share Outstanding at beginning of period 674,753 $ 59.63 Granted 390,975 75.70 Vested (392,001) 59.24 Forfeited (7,724) 66.18 Outstanding at end of period 666,003 $ 62.39 $ 77.29

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interests	6 Months Ended
	Jun. 25, 2022
Redeemable Noncontrolling Interests [Abstract]
Redeemable Noncontrolling Interests	Note 11 – Redeemable Noncontrolling Interests Some minority stockholders in certain of our subsidiaries have the right, their ownership interest in those entities at fair value. applicable for noncontrolling interests where we are or may be required outstanding interest in a consolidated subsidiary from the noncontrolling option contained in contractual agreements. interests for the six months ended June 25, 2022 and the year ended December following table: June 25, December 25, 2022 2021 Balance, beginning of period $ 613 $ 328 Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interests in subsidiaries (11) (60) Increase in redeemable noncontrolling interests due to business acquisitions - 189 Net income attributable to redeemable noncontrolling interests 9 23 Dividends declared (11) (21) Effect of foreign currency translation loss attributable to redeemable noncontrolling interests (7) (6) Change in fair value of redeemable securities (7) 160 Balance, end of period $ 586 $ 613

Comprehensive Income

Comprehensive Income	6 Months Ended
	Jun. 25, 2022
Comprehensive Income [Abstract]
Comprehensive Income	Note 12 – Comprehensive Income Comprehensive income includes certain gains and losses that, under U.S. such amounts are recorded directly as an adjustment to stockholders’ The following table summarizes our Accumulated other comprehensive loss, net of June 25, December 25, 2022 2021 Attributable to Redeemable noncontrolling interests: Foreign currency translation adjustment $ (38) $ (31) Attributable to noncontrolling interests: Foreign currency translation adjustment $ (1) $ - Attributable to Henry Schein, Inc.: Foreign currency translation adjustment $ (234) $ (155) Unrealized gain (loss) from foreign currency hedging activities 7 (2) Pension adjustment loss (14) (14) Accumulated other comprehensive loss $ (241) $ (171) Total Accumulated $ (280) $ (202) The following table summarizes the components of comprehensive income, net Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Net income $ 167 $ 164 $ 353 $ 339 Foreign currency translation gain (loss) (90) 38 (87) - Tax effect - - - - Foreign currency translation gain (loss) (90) 38 (87) - Unrealized gain (loss) from foreign currency hedging 10 (2) 12 2 Tax effect (2) - (3) (1) Unrealized gain (loss) from foreign currency hedging 8 (2) 9 1 Pension adjustment gain - - - 1 Tax effect - - - - Pension adjustment gain - - - 1 Comprehensive income $ 85 $ 200 $ 275 $ 341 The change in the unrealized gain (loss) from foreign currency hedging activities ended June 25, 2022 and June 26, 2021 was primarily attributable during 2019. Our financial statements are denominated in the U.S. Dollar currency. currencies as compared to the U.S. Dollar may have a significant impact foreign currency translation gain (loss) during the six months ended 2021 was primarily impacted by changes in foreign currency exchange rates Real, Australian Dollar and Canadian Dollar. The following table summarizes our total comprehensive income, net of Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Comprehensive income attributable to Henry Schein, Inc. $ 87 $ 185 $ 271 $ 323 Comprehensive income attributable to noncontrolling interests 1 1 2 3 Comprehensive income (loss) attributable to Redeemable noncontrolling interests (3) 14 2 15 Comprehensive income $ 85 $ 200 $ 275 $ 341

Plans of Restructuring

Plans of Restructuring	6 Months Ended
	Jun. 25, 2022
Plans of Restructuring [Abstract]
Plans of Restructuring	Note 13 – Plans of Restructuring On November 20, 2019, we committed to a contemplated restructuring associated with the spin-off of our animal health business and to rationalize operations efficiencies. During the three and six months ended June 26, 2021, we recorded restructuring 1 4 respectively. was $ 1 4 On August 1, 2022, we committed to a restructuring plan focused on funding streamlining operations and other initiatives to increase efficiency. 2022 and 2023, however an estimate of the amount of these charges has not yet been charges are expected primarily to include severance pay and facility-related costs.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 25, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Note 14 Earnings Per Share Basic earnings per share is computed by dividing net income attributable average number of common shares outstanding for the period. to basic earnings per share, except that it reflects the effect of common shares issuable restricted stock and RSUs and upon exercise of stock options using they have a dilutive effect. A reconciliation of shares used in calculating earnings per basic and Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Basic 137,350,488 140,358,428 137,323,076 141,316,258 Effect of dilutive securities: Stock options, restricted stock and restricted stock units 1,518,576 1,298,455 1,732,129 1,221,648 Diluted 138,869,064 141,656,883 139,055,205 142,537,906 The number of antidilutive securities that were excluded from the calculation shares outstanding are as follows: Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Stock options 423,786 786,691 250,226 501,648 Restricted stock units 51,453 2,621 226,203 1,653 Total anti-dilutive computation 475,239 789,312 476,429 503,301

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	6 Months Ended
	Jun. 25, 2022
Supplemental Cash Flow information [Abstract]
Supplemental Cash Flow Information	Note 15 – Supplemental Cash Flow Information Cash paid for interest and income taxes was: Six Months Ended June 25, June 26, 2022 2021 Interest $ 17 $ 14 Income taxes 165 134 During the six months ended June 25, 2022 and June 26, 2021, we had a 12 2 unrealized gains related to foreign currency hedging activities, respectively.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 25, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 16 – Related Party Transactions In connection with the formation of Henry Schein One, LLC, our joint venture formed on July 1, 2018, we entered into a ten-year Internet Brands approximately $ 31 six months ended June 25, 2022, we recorded $ 8 16 related to this royalty agreement. 8 and $ 16 December 25, 2021, of $ (6) 9 agreement. During our normal course of business, we have interests in entities that we account for under the equity accounting method. 16 32 million, respectively, to such entities. of $ 18 33 we purchased $ 5 10 June 26, 2021, we purchased $ 5 9 December 25, 2021, in the aggregate we had $ 40 45 9 million and $ 9 Certain of our facilities related to our acquisitions are leased from employees leases are classified as operating leases and have a remaining lease term 6 months 10 years . June 25, 2022, current and non-current liabilities associated with related 4 $ 17 5.4 % and 6.1 % of the total current and non-current operating lease liabilities.

Critical Accounting Policies,_2

Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards (Policy)	6 Months Ended
	Jun. 25, 2022
Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards [Abstract]
Accounting Pronouncements Adopted and Recently Issued Accounting Standards	Accounting Pronouncements Adopted On December 26, 2021 Contract Assets and Contract Liabilities from Contracts with Customers” ASU was permitted. liabilities acquired in a business combination in accordance with Topic 606. should account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts. To achieve this, an acquirer may assess how the acquiree applied Topic 606 to determine what to record for the acquired revenue contracts. contract assets and contract liabilities consistent with how financial statements. adoption statements. Recently Issued Accounting Standards In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” which provides optional expedients and exceptions for applying U.S. GAAP to contracts, transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or reference rate expected to be discontinued because of reference rate reform. March 12, 2020 and can be applied prospectively through December 31, ASU 2021-01, Reference Rate Reform (Topic 848): Scope (“ASU 2021-01”). optional expedients and exceptions to certain guidance in U.S. GAAP to ease to the expected market transition from LIBOR and other interbank offered rates as the Secured Overnight Financing Rate. applied through December 31, 2022. impact on our consolidated financial statements. In March 2022, the FASB issued ASU No. 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Portfolio Layer Method,” which will expand companies' abilities portfolios of financial assets (or beneficial interests) in a fair value hedge. portfolio layer method (previously referred to as the last-of-layer closed portfolio of assets using spot starting, forward starting and amortizing-notional prepayable and non-prepayable financial assets to be included in the closed layer hedge. portfolio layer method hedges, but rather be maintained on the closed portfolio 01 is effective for fiscal years beginning after December 15, 2022, including interim periods years. expect that the requirements of this guidance will have a material impact In March 2022, the FASB issued ASU No. 2022-02, “Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructuring and Vintage Disclosures”. troubled debt restructurings by creditors that have adopted the Current Expected the disclosure requirements for loan refinancings and restructurings difficulty. for financing receivables and net investment in leases by year of origination – 02 is effective for fiscal years beginning after December 15, 2022, including years. Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”. expect that the requirements of this guidance will have a material impact

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	6 Months Ended
	Jun. 25, 2022
Revenue from Contracts with Customers [Abstract]
Disaggregation of Revenue	Three Months Ended Six Months Ended June 25, 2022 June 25, 2022 North America International Global North America International Global Net Sales: Health care distribution Dental $ 1,124 $ 729 $ 1,853 $ 2,229 $ 1,452 $ 3,681 Medical 977 19 996 2,127 41 2,168 Total health care distribution 2,101 748 2,849 4,356 1,493 5,849 Technology 158 23 181 314 46 360 Total revenues $ 2,259 $ 771 $ 3,030 $ 4,670 $ 1,539 $ 6,209 Three Months Ended Six Months Ended June 26, 2021 June 26, 2021 North America International Global North America International Global Net Sales: Health care distribution Dental $ 1,129 $ 783 $ 1,912 $ 2,174 $ 1,527 $ 3,701 Medical 875 27 902 1,838 55 1,893 Total health care distribution 2,004 810 2,814 4,012 1,582 5,594 Technology 131 22 153 255 43 298 Total revenues $ 2,135 $ 832 $ 2,967 $ 4,267 $ 1,625 $ 5,892

Segment Data (Tables)

Segment Data (Tables)	6 Months Ended
	Jun. 25, 2022
Segment Data [Abstract]
Business segment information	Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Net Sales: Health care distribution Dental $ 1,853 $ 1,912 $ 3,681 $ 3,701 Medical 996 902 2,168 1,893 Total health care distribution 2,849 2,814 5,849 5,594 Technology 181 153 360 298 Total $ 3,030 $ 2,967 $ 6,209 $ 5,892 Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Operating Income: Health care distribution $ 189 $ 182 $ 400 $ 379 Technology 31 28 64 61 Total $ 220 $ 210 $ 464 $ 440

Business Acquisitions (Tables)

Business Acquisitions (Tables)	6 Months Ended
	Jun. 25, 2022
Business Acquisitions [Abstract]
Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired	Acquisition consideration: Cash $ 303 Deferred consideration 8 Redeemable noncontrolling interests 129 Total consideration $ 440 Identifiable assets acquired and liabilities assumed: Current assets 107 Intangible assets 184 Other noncurrent assets 34 Current liabilities (44) Deferred income taxes (17) Other noncurrent liabilities (37) Total identifiable 227 Goodwill 213 Total net assets acquired $ 440
Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives	Estimated Useful Lives (in years) Customer relationships and lists $ 124 5 - 12 Trademark / Tradename 33 5 - 7 Non-compete agreements 6 5 Product development 21 5 - 7 Total $ 184

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 25, 2022
Fair Value Measurements [Abstract]
Fair value - assets and liabilities measured and recognized on a recurring basis	June 25, 2022 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 23 $ - $ 23 Derivative contracts undesignated - 2 - 2 Total assets $ - $ 25 $ - $ 25 Liabilities: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 5 - 5 Total return - 5 - 5 Total liabilities $ - $ 11 $ - $ 11 Redeemable noncontrolling interests $ - $ - $ 586 $ 586 December 25, 2021 Level 1 Level 2 Level 3 Total Assets: Derivative contracts designated as hedges $ - $ 8 $ - $ 8 Derivative contracts undesignated - 1 - 1 Total return - 1 - 1 Total assets $ - $ 10 $ - $ 10 Liabilities: Derivative contracts designated as hedges $ - $ 1 $ - $ 1 Derivative contracts undesignated - 2 - 2 Total liabilities $ - $ 3 $ - $ 3 Redeemable noncontrolling interests $ - $ - $ 613 $ 613

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 25, 2022
Debt [Abstract]
Bank credit lines	June 25, December 25, 2022 2021 Revolving credit agreement $ - $ - Other short-term bank credit lines 85 51 Total $ 85 $ 51
Long-term debt	June 25, December 25, 2022 2021 Private placement facilities $ 699 $ 706 U.S. trade accounts receivable securitization 60 105 Various in varying installments through 2023 at interest rates ranging from 0.00 % to 3.50 % at June 25, 2022 and ranging from 2.62 % to 4.27 % at December 25, 2021 7 4 Finance lease obligations 7 7 Total 773 822 Less current maturities (4) (11) Total long-term debt $ 769 $ 811
Private placement facilities	Amount of Borrowing Borrowing Date of Borrowing Outstanding Rate Due Date January 20, 2012 $ 50 3.45 % January 20, 2024 December 24, 2012 50 3.00 December 24, 2024 June 16, 2017 100 3.42 June 16, 2027 September 15, 2017 100 3.52 September 15, 2029 January 2, 2018 100 3.32 January 2, 2028 September 2, 2020 100 2.35 September 2, 2030 June 2, 2021 100 2.48 June 2, 2031 June 2, 2021 100 2.58 June 2, 2033 Less: Deferred debt issuance costs (1) Total $ 699

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 25, 2022
Stock-Based Compensation [Abstract]
Assumptions used in Determining Fair Values of Stock Options using the Black-Scholes Valuation Model	2022 Expected dividend yield 0.0 % Expected stock price volatility 27.40 % Risk-free interest rate 3.25 % Expected life of options (years) 6.00
Summary of Stock Option Activity Under the Plans	Stock Options Weighted Average Weighted Remaining Average Contractual Aggregate Exercise Life in Shares Price Years Outstanding at beginning of period 767,717 $ 63.24 Granted 406,443 86.16 Exercised (29,892) 62.71 Forfeited (9,656) 71.72 Outstanding at end of period 1,134,612 $ 71.39 9.1 $ 10 Options exercisable at end of period 219,642 $ 62.92
Intrinsic Values	Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Options Price Life (in years) Value Vested 894,356 $ 73.68 9.2 $ 7
Status of Non-Vested Restricted Shares/Units	Time-Based Restricted Stock Units Weighted Average Grant Date Fair Intrinsic Value Shares/Units Value Per Share Per Share Outstanding at beginning of period 1,945,862 $ 58.79 Granted 455,169 86.13 Vested (501,944) 54.76 Forfeited (28,807) 65.88 Outstanding at end of period 1,870,280 $ 66.47 $ 77.29 Performance-Based Restricted Stock Units Weighted Average Grant Date Fair Intrinsic Value Shares/Units Value Per Share Per Share Outstanding at beginning of period 674,753 $ 59.63 Granted 390,975 75.70 Vested (392,001) 59.24 Forfeited (7,724) 66.18 Outstanding at end of period 666,003 $ 62.39 $ 77.29

Redeemable Noncontrolling Int_2

Redeemable Noncontrolling Interests (Tables)	6 Months Ended
	Jun. 25, 2022
Redeemable Noncontrolling Interests [Abstract]
Components of the Change in Redeemable Noncontrolling Interests	June 25, December 25, 2022 2021 Balance, beginning of period $ 613 $ 328 Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interests in subsidiaries (11) (60) Increase in redeemable noncontrolling interests due to business acquisitions - 189 Net income attributable to redeemable noncontrolling interests 9 23 Dividends declared (11) (21) Effect of foreign currency translation loss attributable to redeemable noncontrolling interests (7) (6) Change in fair value of redeemable securities (7) 160 Balance, end of period $ 586 $ 613

Comprehensive Income (Tables)

Comprehensive Income (Tables)	6 Months Ended
	Jun. 25, 2022
Comprehensive Income [Abstract]
Accumulated Other Comprehensive Loss Net of Applicable Taxes	June 25, December 25, 2022 2021 Attributable to Redeemable noncontrolling interests: Foreign currency translation adjustment $ (38) $ (31) Attributable to noncontrolling interests: Foreign currency translation adjustment $ (1) $ - Attributable to Henry Schein, Inc.: Foreign currency translation adjustment $ (234) $ (155) Unrealized gain (loss) from foreign currency hedging activities 7 (2) Pension adjustment loss (14) (14) Accumulated other comprehensive loss $ (241) $ (171) Total Accumulated $ (280) $ (202)
Components of Comprehensive Income, Net of Applicable Taxes	Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Net income $ 167 $ 164 $ 353 $ 339 Foreign currency translation gain (loss) (90) 38 (87) - Tax effect - - - - Foreign currency translation gain (loss) (90) 38 (87) - Unrealized gain (loss) from foreign currency hedging 10 (2) 12 2 Tax effect (2) - (3) (1) Unrealized gain (loss) from foreign currency hedging 8 (2) 9 1 Pension adjustment gain - - - 1 Tax effect - - - - Pension adjustment gain - - - 1 Comprehensive income $ 85 $ 200 $ 275 $ 341
Total Comprehensive Income, Net of Applicable Taxes	Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Comprehensive income attributable to Henry Schein, Inc. $ 87 $ 185 $ 271 $ 323 Comprehensive income attributable to noncontrolling interests 1 1 2 3 Comprehensive income (loss) attributable to Redeemable noncontrolling interests (3) 14 2 15 Comprehensive income $ 85 $ 200 $ 275 $ 341

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 25, 2022
Earnings Per Share [Abstract]
Reconciliation of Shares used in Calculating Earnings per Share Basic and Diluted	Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Basic 137,350,488 140,358,428 137,323,076 141,316,258 Effect of dilutive securities: Stock options, restricted stock and restricted stock units 1,518,576 1,298,455 1,732,129 1,221,648 Diluted 138,869,064 141,656,883 139,055,205 142,537,906
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Three Months Ended Six Months Ended June 25, June 26, June 25, June 26, 2022 2021 2022 2021 Stock options 423,786 786,691 250,226 501,648 Restricted stock units 51,453 2,621 226,203 1,653 Total anti-dilutive computation 475,239 789,312 476,429 503,301

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	6 Months Ended
	Jun. 25, 2022
Supplemental Cash Flow information [Abstract]
Cash paid for interest and income taxes	Six Months Ended June 25, June 26, 2022 2021 Interest $ 17 $ 14 Income taxes 165 134

Basis of Presentation - Narrati

Basis of Presentation - Narrative (Details) - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021
Pledged assets	$ 76	$ 138
Liabilities of VIE	$ 60	$ 105

Critical Accounting Policies,_3

Critical Accounting Policies, Accounting Pronouncements Adopted and Recently Issued Accounting Standards - Narrative (Details) - Accounting Standards Update 2021-08 [Member]	Jun. 25, 2022
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]	true
Change in Accounting Principle, Accounting Standards Update, Adoption Date	Dec. 26, 2021

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Narrative (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 25, 2022	Dec. 25, 2021
Revenue from Contracts with Customers [Abstract]
Contract with Customer, Liability, Current	$ 87	$ 89
Contract with Customer, Liability, Noncurrent	9	$ 10
Contract with Customer, Liability, Revenue Recognized	$ 56

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Disaggregation of Revenue [Abstract]
Net sales	$ 3,030	$ 2,967	$ 6,209	$ 5,892
North America [Member]
Disaggregation of Revenue [Abstract]
Net sales	2,259	2,135	4,670	4,267
International [Member]
Disaggregation of Revenue [Abstract]
Net sales	771	832	1,539	1,625
Healthcare Distribution [Member]
Disaggregation of Revenue [Abstract]
Net sales	2,849	2,814	5,849	5,594
Healthcare Distribution [Member] | North America [Member]
Disaggregation of Revenue [Abstract]
Net sales	2,101	2,004	4,356	4,012
Healthcare Distribution [Member] | International [Member]
Disaggregation of Revenue [Abstract]
Net sales	748	810	1,493	1,582
Healthcare Distribution [Member] | Dental [Member]
Disaggregation of Revenue [Abstract]
Net sales	1,853	1,912	3,681	3,701
Healthcare Distribution [Member] | Dental [Member] | North America [Member]
Disaggregation of Revenue [Abstract]
Net sales	1,124	1,129	2,229	2,174
Healthcare Distribution [Member] | Dental [Member] | International [Member]
Disaggregation of Revenue [Abstract]
Net sales	729	783	1,452	1,527
Healthcare Distribution [Member] | Medical [Member]
Disaggregation of Revenue [Abstract]
Net sales	996	902	2,168	1,893
Healthcare Distribution [Member] | Medical [Member] | North America [Member]
Disaggregation of Revenue [Abstract]
Net sales	977	875	2,127	1,838
Healthcare Distribution [Member] | Medical [Member] | International [Member]
Disaggregation of Revenue [Abstract]
Net sales	19	27	41	55
Technology [Member]
Disaggregation of Revenue [Abstract]
Net sales	181	153	360	298
Technology [Member] | North America [Member]
Disaggregation of Revenue [Abstract]
Net sales	158	131	314	255
Technology [Member] | International [Member]
Disaggregation of Revenue [Abstract]
Net sales	$ 23	$ 22	$ 46	$ 43

Segment Data (Details)

Segment Data (Details) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022 USD ($) countries	Jun. 26, 2021 USD ($)	Jun. 25, 2022 USD ($) segments countries	Jun. 26, 2021 USD ($)
Segment Data [Abstract]
Number of reportable segments | segments			2
Segment Reporting Information [Line Items]
Net sales	$ 3,030	$ 2,967	$ 6,209	$ 5,892
Operating income	220	210	464	440
Healthcare Distribution [Member]
Segment Reporting Information [Line Items]
Net sales	2,849	2,814	5,849	5,594
Operating income	$ 189	182	$ 400	379
Number of countries served globally | countries	32		32
Healthcare Distribution [Member] | Dental [Member]
Segment Reporting Information [Line Items]
Net sales	$ 1,853	1,912	$ 3,681	3,701
Healthcare Distribution [Member] | Medical [Member]
Segment Reporting Information [Line Items]
Net sales	996	902	2,168	1,893
Technology and Value-Added Services [Member]
Segment Reporting Information [Line Items]
Net sales	181	153	360	298
Operating income	$ 31	$ 28	$ 64	$ 61

Business Acquisitions - Narrati

Business Acquisitions - Narrative (Details) - USD ($) $ in Millions	Jun. 25, 2022	Jun. 26, 2021
Business Acquisition [Line Items]
Acquisition costs	$ 3	$ 4
Series Of Individually Immaterial Business Acquisitions [Member] | Minimum [Member]
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired		51%
Series Of Individually Immaterial Business Acquisitions [Member] | Maximum [Member]
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired		100%

Business Acquisitions - Summary

Business Acquisitions - Summary of Estimated Fair Value of Consideration Paid and Net Assets Acquired (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 26, 2021	Jun. 26, 2021	Jun. 25, 2022	Dec. 25, 2021
Acquisition consideration:
Initial noncontrolling interest and adjustments related to business acquisitions	$ 6	$ 7
Identifiable assets acquired and liabilities assumed:
Goodwill			$ 2,833	$ 2,854
Series Of Individually Immaterial Business Acquisitions [Member]
Acquisition consideration:
Cash		303
Deferred consideration		8
Initial noncontrolling interest and adjustments related to business acquisitions		129
Total consideration		440
Identifiable assets acquired and liabilities assumed:
Current assets	107	107
Intangible assets	184	184
Other noncurrent assets	34	34
Current liabilities	(44)	(44)
Deferred income taxes	(17)	(17)
Other noncurrent liabilities	(37)	(37)
Total identifiable net assets	227	227
Goodwill	213	213
Total net assets acquired	$ 440	$ 440

Business Acquisitions - Summa_2

Business Acquisitions - Summary of Identifiable Intangible Assets Acquired and Estimated Useful Lives (Details) - Series Of Individually Immaterial Business Acquisitions [Member] $ in Millions	6 Months Ended
	Jun. 26, 2021 USD ($)
Acquired Finite Lived Intangible Assets [Line Items]
Identifiable Intangible Assets Acquired	$ 184
Customer Relationships and Lists [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Identifiable Intangible Assets Acquired	124
Tradename/Trademark [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Identifiable Intangible Assets Acquired	33
Non-compete Agreements [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Identifiable Intangible Assets Acquired	$ 6
Estimated Useful Lives (in years)	5 years
Product Development [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Identifiable Intangible Assets Acquired	$ 21
Minimum [Member] | Customer Relationships and Lists [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	5 years
Minimum [Member] | Tradename/Trademark [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	5 years
Minimum [Member] | Product Development [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	5 years
Maximum [Member] | Customer Relationships and Lists [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	12 years
Maximum [Member] | Tradename/Trademark [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	7 years
Maximum [Member] | Product Development [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Useful Lives (in years)	7 years

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021	Dec. 26, 2020
Attributable To Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	$ 586	$ 613	$ 328
Fair value, measurements, recurring [Member] | Fair Value Measurement [Domain]
Assets [Abstract]
Total assets	25	10
Liabilities [Abstract]
Total liabilities	11	3
Fair value, measurements, recurring [Member] | Fair Value Measurement [Domain] | Derivative contracts designated as hedges [Member]
Assets [Abstract]
Derivative contracts - assets	23	8
Liabilities [Abstract]
Derivative contracts - liabilities	1	1
Fair value, measurements, recurring [Member] | Fair Value Measurement [Domain] | Derivative contracts undesignated [Member]
Assets [Abstract]
Derivative contracts - assets	2	1
Liabilities [Abstract]
Derivative contracts - liabilities	5	2
Fair value, measurements, recurring [Member] | Fair Value Measurement [Domain] | Total return swap [Member]
Assets [Abstract]
Total return swaps		1
Liabilities [Abstract]
Total return swaps	5
Fair value, measurements, recurring [Member]
Attributable To Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	586	613
Fair value, measurements, recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain]
Assets [Abstract]
Total assets	0	0
Liabilities [Abstract]
Total liabilities	0	0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain] | Derivative contracts designated as hedges [Member]
Assets [Abstract]
Derivative contracts - assets	0	0
Liabilities [Abstract]
Derivative contracts - liabilities	0	0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain] | Derivative contracts undesignated [Member]
Assets [Abstract]
Derivative contracts - assets	0	0
Liabilities [Abstract]
Derivative contracts - liabilities	0	0
Fair value, measurements, recurring [Member] | Level 1 [Member] | Fair Value Measurement [Domain] | Total return swap [Member]
Assets [Abstract]
Total return swaps		0
Liabilities [Abstract]
Total return swaps	0
Fair value, measurements, recurring [Member] | Level 1 [Member]
Attributable To Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	0	0
Fair value, measurements, recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain]
Assets [Abstract]
Total assets	25	10
Liabilities [Abstract]
Total liabilities	11	3
Fair value, measurements, recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain] | Derivative contracts designated as hedges [Member]
Assets [Abstract]
Derivative contracts - assets	23	8
Liabilities [Abstract]
Derivative contracts - liabilities	1	1
Fair value, measurements, recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain] | Derivative contracts undesignated [Member]
Assets [Abstract]
Derivative contracts - assets	2	1
Liabilities [Abstract]
Derivative contracts - liabilities	5	2
Fair value, measurements, recurring [Member] | Level 2 [Member] | Fair Value Measurement [Domain] | Total return swap [Member]
Assets [Abstract]
Total return swaps		1
Liabilities [Abstract]
Total return swaps	5
Fair value, measurements, recurring [Member] | Level 2 [Member]
Attributable To Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	0	0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain]
Assets [Abstract]
Total assets	0	0
Liabilities [Abstract]
Total liabilities	0	0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain] | Derivative contracts designated as hedges [Member]
Assets [Abstract]
Derivative contracts - assets	0	0
Liabilities [Abstract]
Derivative contracts - liabilities	0	0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain] | Derivative contracts undesignated [Member]
Assets [Abstract]
Derivative contracts - assets	0	0
Liabilities [Abstract]
Derivative contracts - liabilities		0
Fair value, measurements, recurring [Member] | Level 3 [Member] | Fair Value Measurement [Domain] | Total return swap [Member]
Assets [Abstract]
Total return swaps		0
Liabilities [Abstract]
Total return swaps	0
Fair value, measurements, recurring [Member] | Level 3 [Member]
Attributable To Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	586	613
Fair value, measurements, recurring [Member] | Level 3 [Member] | Estimate of Fair Value Measurement [Member]
Debt Instrument, Fair Value Disclosure [Abstract]
Fair value of debt (including bank credit lines)	$ 858	$ 873

Debt - Bank credit lines (Detai

Debt - Bank credit lines (Details) - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021
Line of Credit Facility [Line Items]
Bank Credit lines	$ 85	$ 51
Revolving Credit Agreement [Member]
Line of Credit Facility [Line Items]
Bank Credit lines	0	0
Other Short Term Credit Lines [Member]
Line of Credit Facility [Line Items]
Bank Credit lines	$ 85	$ 51

Debt - Revolving Credit Agreeme

Debt - Revolving Credit Agreement and Other Short-Term Credit Lines Narrative (Details) - USD ($)	6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Dec. 25, 2021	Aug. 20, 2021	Aug. 19, 2021
Line of Credit Facility [Line Items]
Bank credit lines	$ 85,000,000		$ 51,000,000
Repayments of Long-term Debt	$ 57,000,000	$ 120,000,000
Revolving Credit Agreement [Member]
Line of Credit Facility [Line Items]
Line of Credit Facility, Initiation Date	Aug. 20, 2021
Revolving credit facility borrowing capacity				$ 1,000,000,000	$ 750,000,000
Revolving credit facility expiration date	Aug. 20, 2026
Borrowings	$ 0		0
Outstanding letters of credit provided to third parties	9,000,000		9,000,000
Bank credit lines	0		0
Other Short Term Credit Lines [Member]
Line of Credit Facility [Line Items]
Bank credit lines	$ 85,000,000		$ 51,000,000
Weighted average interest rate on borrowings under credit lines at period end (in hundredths)	9.90%		10.44%

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($) $ in Millions	Jun. 25, 2022	Dec. 25, 2021
Debt Instrument [Line Items]
Finance lease obligations	$ 7	$ 7
Total	773	822
Less current maturities	(4)	(11)
Long-term debt	769	811
Private placement facilities [Member]
Debt Instrument [Line Items]
Long-term debt	699	706
U.S. Trade Accounts Receivable Securitization [Member]
Debt Instrument [Line Items]
Long-term debt	60	105
Total	60	105
Various collateralized and uncollateralized loans payable with interest in varying installments through 2023 at interest rates ranging from 0% to 4.27% at March 26, 2022 and ranging from 2.62% to 4.27% at December 25, 2021 [Member]
Debt Instrument [Line Items]
Long-term debt	$ 7	$ 4
Various collateralized and uncollateralized loans payable with interest in varying installments through 2023 at interest rates ranging from 0% to 4.27% at March 26, 2022 and ranging from 2.62% to 4.27% at December 25, 2021 [Member] | Minimum [Member]
Debt Instrument [Line Items]
Borrowing Rate	0%	2.62%
Various collateralized and uncollateralized loans payable with interest in varying installments through 2023 at interest rates ranging from 0% to 4.27% at March 26, 2022 and ranging from 2.62% to 4.27% at December 25, 2021 [Member] | Maximum [Member]
Debt Instrument [Line Items]
Borrowing Rate	3.50%	4.27%

Debt - Private Placement Facili

Debt - Private Placement Facilities - Narrative (Details) - Private Placement Facilities [Member]		6 Months Ended
	Oct. 19, 2021 USD ($)	Jun. 25, 2022	Oct. 20, 2021 USD ($)
Debt Instrument [Line Items]
Date of borrowing		Oct. 20, 2021
Number of companies included in private placement facilities	3		4
Debt instrument maximum borrowing capacity	$ 1,000,000,000		$ 1,500,000,000
Debt instrument, maturity date	Jun. 23, 2023	Oct. 20, 2026
Average term of issuances under private placement facilities		12 years
Private placement facilities maturing in September 2030 [Member]
Debt Instrument [Line Items]
Date of borrowing		Sep. 02, 2020
Debt instrument, maturity date		Sep. 02, 2030
Private placement facilities maturing in June 2031 [Member]
Debt Instrument [Line Items]
Date of borrowing		Jun. 02, 2021
Debt instrument, maturity date		Jun. 02, 2031
Minimum [Member]
Debt Instrument [Line Items]
Term of issuances under private placement facilities		5 years
Maximum [Member]
Debt Instrument [Line Items]
Term of issuances under private placement facilities		15 years

Debt - Private Placement Borrow

Debt - Private Placement Borrowings (Details) - Private placement facilities [Member] - USD ($) $ in Millions		6 Months Ended
	Oct. 19, 2021	Jun. 25, 2022	Dec. 25, 2021
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Oct. 20, 2021
Long-term Debt, Gross		$ 699
Less: Deferred debt issuance costs		(1)
Total		$ 699	$ 706
Debt Instrument, Maturity Date	Jun. 23, 2023	Oct. 20, 2026
Private placement facilities maturing in January 2024 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Jan. 20, 2012
Long-term Debt, Gross		$ 50
Borrowing Rate		3.45%
Debt Instrument, Maturity Date		Jan. 20, 2024
Private placement facilities maturing in December 2024 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Dec. 24, 2012
Long-term Debt, Gross		$ 50
Borrowing Rate		3%
Debt Instrument, Maturity Date		Dec. 24, 2024
Private Placement facilities maturing in June 2027 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Jun. 16, 2017
Long-term Debt, Gross		$ 100
Borrowing Rate		3.42%
Debt Instrument, Maturity Date		Jun. 16, 2027
Private Placement facilities maturing in September 2029 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Sep. 15, 2017
Long-term Debt, Gross		$ 100
Borrowing Rate		3.52%
Debt Instrument, Maturity Date		Sep. 15, 2029
Private Placement facilities maturing in January 2028 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Jan. 02, 2018
Long-term Debt, Gross		$ 100
Borrowing Rate		3.32%
Debt Instrument, Maturity Date		Jan. 02, 2028
Private placement facilities maturing in September 2030 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Sep. 02, 2020
Long-term Debt, Gross		$ 100
Borrowing Rate		2.35%
Debt Instrument, Maturity Date		Sep. 02, 2030
Private placement facilities maturing in June 2031 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Jun. 02, 2021
Long-term Debt, Gross		$ 100
Borrowing Rate		2.48%
Debt Instrument, Maturity Date		Jun. 02, 2031
Private Placement Facilities maturing in June 2033 [Member]
Debt Instrument [Line Items]
Debt Instrument, Issuance Date		Jun. 02, 2021
Long-term Debt, Gross		$ 100
Borrowing Rate		2.58%
Debt Instrument, Maturity Date		Jun. 02, 2033

Debt - U.S. Trade Accounts Rece

Debt - U.S. Trade Accounts Receivable Securitization - Narrative (Details) - U.S. Trade Accounts Receivable Securitization [Member]		6 Months Ended	12 Months Ended
	Oct. 19, 2021 USD ($)	Jun. 25, 2022 USD ($)	Dec. 25, 2021 USD ($)	Oct. 20, 2021 USD ($)
Debt Instrument [Line Items]
Pricing commitment period		3 years
Debt Instrument, Maturity Date	Apr. 29, 2022	Oct. 18, 2024
Debt instrument maximum borrowing capacity	$ 350,000,000			$ 450,000,000
Long-term debt		$ 60,000,000	$ 105,000,000
Commitment fee for facility usage - facility limit greater than or equal to fifty percent usage (as a percent)		0.35%
Commitment fee for facility usage - facility limit less than fifty percent usage (as a percent)		0.30%
Number of banks as agents for debt instrument				2
Average Asset Backed Commercial Paper Rate [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate at period end		2.18%	0.94%
Debt instrument, variable rate basis at period end		1.43%	0.19%
Debt instrument, basis spread on variable rate		0.75%	0.75%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 25, 2022	Dec. 25, 2021	Jun. 26, 2021
Income Tax Examination [Line Items]
Effective tax rate	23.90%	24.30%
Unrecognized tax benefits	$ 83,000,000	$ 84,000,000
Tax interest expense (credit)	0		$ (3,000,000)
Total interest	13,000,000	12,000,000
Total penalties	0	0
Unrecognized tax benefits that would affect the effective tax rate if recognized	$ 69,000,000	$ 69,000,000

Legal Proceedings - Narrative (

Legal Proceedings - Narrative (Details)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 25, 2022 USD ($) claims	Jun. 26, 2021 USD ($)	Jun. 25, 2022 USD ($) claims	Jun. 26, 2021 USD ($)	Dec. 25, 2021 USD ($)
Loss Contingency, Information about Litigation Matters [Abstract]
Revenues | $	$ 3,030,000,000	$ 2,967,000,000	$ 6,209,000,000	$ 5,892,000,000
Maximum [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Loss Contingency, Pending Claims, Number | claims	175		175
Actions consolidated in the MultiDistrict Litigation [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Maximum sales of opioids in North America during the year, percentage					0.20%
Actions consolidated in the MultiDistrict Litigation [Member] | Continuing Operations [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Revenues | $					$ 12,400,000,000
Hospitals in West Virginia [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Number of claims settled | claims			26
Number of claims dismissed			26
Additional Hospital [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Number of claims settled | claims			1
Litigation settlements | $			$ 300,000
Other Hospitals Located throughout Florida [Member]
Loss Contingency, Information about Litigation Matters [Abstract]
Number of plaintiffs			38

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average period of recognition for unrecognized compensation costs on nonvested awards (in years)			2 years 4 months 24 days
Total unrecognized compensation cost related to non-vested awards	$ 116,000,000		$ 116,000,000
Excess Tax Benefit from Share-based Compensation, Financing Activities			0	$ 0
After-tax share-based compensation (credit) expense	12,000,000	$ 13,000,000	21,000,000	23,000,000
Pre-tax share-based compensation (Credit) expense	$ 15,000,000	$ 17,000,000	$ 27,000,000	$ 30,000,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			3 years
Percentage of stock options vest per year			33.33%
Expiration period (in years)			10 years
Time-Based Restricted Stock Restricted Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			4 years
Time-Based Restricted Stock Restricted Units [Member] | 2015 Non-Employee Director Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			12 months
Special Pandemic Recognition Award [Member] | 2020 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			2 years
Stock based compensation percentage of options vest per year first anniversary			50%
Stock based compensation percentage of options vest per year second anniversary			50%
Cumulative percentage payout based on actual performance and one-time special award			75%
Performance-Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			3 years
Performance-Based Restricted Stock Units [Member] | 2020 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage payout based on actual performance			20%
Performance-Based Restricted Stock Units [Member] | 2018 Long-Term Incentive Program [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			3 years

Stock-Based Compensation - Assu

Stock-Based Compensation - Assumptions used in Determining Fair Values of Stock Options using the Black-Scholes Valuation Model (Details)	6 Months Ended
	Jun. 25, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected dividend yield	0%
Expected stock price volatility	27.40%
Risk-free interest rate	3.25%
Expected life of options (years)	6 years

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity under the Plans (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 25, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period (in shares)	767,717
Granted (in shares)	406,443
Exercised (in shares)	(29,892)
Forfeited (in shares)	(9,656)
Outstanding at end of period (in shares)	1,134,612
Weighted Average Exercise Price Per Share [Abstract]
Outstanding at beginning of period (in dollars per share)	$ 63.24
Granted (in dollars per share)	86.16
Exercised (in dollars per share)	62.71
Forfeited (in dollars per share)	71.72
Outstanding at end of period (in dollars per share)	$ 71.39
Outstanding at end of period, Weighted Average Remaining Contractual Life in Years	9 years 1 month 6 days
Outstanding at end of period, Aggregate Intrinsic Value	$ 10
Options exercisable (in shares)	219,642
Weighted average exercise price, options exercisable (in dollars per share)	$ 62.92

Stock-Based Compensation - Intr

Stock-Based Compensation - Intrinsic Values (Details) $ / shares in Units, $ in Millions	6 Months Ended
	Jun. 25, 2022 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options | shares	894,356
Weighted Average Exercise Price | $ / shares	$ 73.68
Weighted Average Remaining Contractual Life (in years)	9 years 2 months 12 days
Aggregate Intrinsic Value | $	$ 7

Stock-Based Compensation - Stat

Stock-Based Compensation - Status of Non-Vested Restricted Shares/Units (Details)	6 Months Ended
	Jun. 25, 2022 $ / shares shares
Time-Based Restricted Stock Restricted Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance outstanding (in shares) | shares	1,945,862
Granted (in shares) | shares	455,169
Vested (in shares) | shares	(501,944)
Forfeited (in shares) | shares	(28,807)
Ending balance outstanding (in shares) | shares	1,870,280
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance outstanding (in dollars per share)	$ 58.79
Granted (in dollars per share)	86.13
Vested (in dollars per share)	54.76
Forfeited (in dollars per share)	65.88
Ending balance outstanding (in dollars per share)	66.47
Aggregate intrinsic value	$ 77.29
Performance-Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance outstanding (in shares) | shares	674,753
Granted (in shares) | shares	390,975
Vested (in shares) | shares	(392,001)
Forfeited (in shares) | shares	(7,724)
Ending balance outstanding (in shares) | shares	666,003
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance outstanding (in dollars per share)	$ 59.63
Granted (in dollars per share)	75.70
Vested (in dollars per share)	59.24
Forfeited (in dollars per share)	66.18
Ending balance outstanding (in dollars per share)	62.39
Aggregate intrinsic value	$ 77.29

Redeemable Noncontrolling Int_3

Redeemable Noncontrolling Interests - Components of the Change in Redeemable Noncontrolling Interests (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021	Dec. 25, 2021
Components of the change in the redeemable noncontrolling interests [Abstract]
Balance, beginning of period			$ 613	$ 328	$ 328
Decrease in redeemable noncontrolling interests due to acquisitions of noncontrolling interest in subsidiaries			(11)		(60)
Increase in redeemable noncontrolling interests due to business acquisitions			0		189
Net income attributable to Redeemable noncontrolling interests	$ 5	$ 7	9	14	23
Dividends declared			(11)		(21)
Effect of foreign currency translation gain (loss) attributable to redeemable noncontrolling interests	(8)	$ 7	(7)	$ 1	(6)
Change in fair value of redeemable securities			(7)		160
Balance, end of period	$ 586		$ 586		$ 613

Comprehensive Income - Accumula

Comprehensive Income - Accumulated Other Comprehensive Income and Comprehensive Income Components (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021	Dec. 25, 2021
Attributable to Redeemable noncontrolling interests:
Foreign currency translation adjustment	$ (38)		$ (38)		$ (31)
Attributable to noncontrolling interests:
Foreign currency translation adjustment	(1)		(1)		0
Attributable to Henry Schein, Inc.:
Foreign currency translation adjustment	(234)		(234)		(155)
Unrealized gain (loss) from foreign currency hedging activities	7		7		(2)
Pension adjustment loss	(14)		(14)		(14)
Accumulated other comprehensive loss	(241)		(241)		(171)
Total Accumulated other comprehensive income (loss)	(280)		(280)		$ (202)
Components of Comprehensive Income
Net Income (loss)	167	$ 164	353	$ 339
Foreign currency translation gain (loss)	(90)	38	(87)	0
Tax effect	0	0	0	0
Foreign currency translation gain (loss)	(90)	38	(87)	0
Unrealized gain (loss) from foreign currency hedging activities	10	(2)	12	2
Tax effect	(2)	0	(3)	(1)
Unrealized gain (loss) from foreign currency hedging activities	8	(2)	9	1
Pension adjustment gain	0	0	0	1
Tax effect	0	0	0	0
Pension adjustment gain	0	0	0	1
Comprehensive income	$ 85	$ 200	$ 275	$ 341

Comprehensive Income - Total Co

Comprehensive Income - Total Comprehensive Income, Net of Applicable Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Comprehensive Income Net Of Applicable Taxes [Abstract]
Comprehensive income attributable to Henry Schein, Inc.	$ 87	$ 185	$ 271	$ 323
Comprehensive income attributable to noncontrolling interests	1	1	2	3
Comprehensive income attributable to Redeemable noncontrolling interests	(3)	14	2	15
Comprehensive income	$ 85	$ 200	$ 275	$ 341

Plans of Restructuring - Narrat

Plans of Restructuring - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 26, 2021	Jun. 26, 2021	Jun. 25, 2022	Dec. 25, 2021
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 1	$ 4
Restructuring accrual			$ 1	$ 4

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	475,239	789,312	476,429	503,301
Employee Stock Option [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	423,786	786,691	250,226	501,648
Restricted Stock Units R S U [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	51,453	2,621	226,203	1,653

Earnings Per Share - Reconcilia

Earnings Per Share - Reconciliation of Shares used in Calculating Earnings per Share Basic and Diluted (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Weighted-average common shares outstanding:
Basic (in shares)	137,350,488	140,358,428	137,323,076	141,316,258
Effect of dilutive securities:
Stock options, restricted stock and restricted stock units	1,518,576	1,298,455	1,732,129	1,221,648
Diluted (in shares)	138,869,064	141,656,883	139,055,205	142,537,906

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	475,239	789,312	476,429	503,301
Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	423,786	786,691	250,226	501,648
Restricted Stock Units R S U [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from EPS	51,453	2,621	226,203	1,653

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021
Supplemental Cash Flow Information [Abstract]
Interest			$ 17	$ 14
Income taxes			165	134
Unrealized gain (loss) from foreign currency hedging activities	$ 10	$ (2)	$ 12	$ 2

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 25, 2022	Jun. 26, 2021	Jun. 25, 2022	Jun. 26, 2021	Dec. 25, 2021
Related Party Transaction [Line Items]
Current operating lease liabilities	$ 74		$ 74		$ 76
Noncurrent operating lease liabilities	276		$ 276		268
Equity Method Investee [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Description of Transaction			During our normal course of business, we have interests in entities that we account for under the equity accounting method.
Due to related party	9		$ 9		9
Due from related party	40		40		45
Revenue from Related Parties	16	$ 18	32	$ 33
Related Party Transaction, Purchases from Related Party	5	5	$ 10	9
Internet Brands Inc [Member] | Royalty Agreements [Member]
Related Party Transaction [Line Items]
Period Covered By Agreement			10 years
Related party agreement amount			$ 31
Related Party Transaction, Expenses from Transactions with Related Party	8	$ 8	16	$ 16
Related Party Transaction, Due from (to) Related Party	(6)		(6)		$ 9
Employees and Minority Shareholders [Member]
Related Party Transaction [Line Items]
Current operating lease liabilities	4		4
Noncurrent operating lease liabilities	$ 17		$ 17
Employees and Minority Shareholders [Member] | Operating Lease Liabilities, Current [Member] | Lessor Concentration Risk [Member]
Related Party Transaction [Line Items]
Concentration risk percentage			5.40%
Employees and Minority Shareholders [Member] | Operating Lease Liabilities, Non-Current [Member] | Lessor Concentration Risk [Member]
Related Party Transaction [Line Items]
Concentration risk percentage			6.10%
Employees and Minority Shareholders [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Remaining operating lease term	6 months		6 months
Employees and Minority Shareholders [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Remaining operating lease term	10 years		10 years